Literature DB >> 27173082

Intrauterine adhesion prevention after hysteroscopy: a systematic review and meta-analysis.

Mae Wu Healy1, Brian Schexnayder2, Matthew T Connell3, Nancy Terry4, Alan H DeCherney5, John M Csokmay3, Belinda J Yauger3, Micah J Hill3.   

Abstract

BACKGROUND: Despite years of studies evaluating prevention strategies for intrauterine adhesion formation after operative hysteroscopy, it is still unclear which strategies are most effective.
OBJECTIVE: The objective of the study was to perform a systematic review and meta-analysis to evaluate the effectiveness of postoperative prevention strategies on intrauterine adhesion formation following operative hysteroscopy. STUDY
DESIGN: Literature searches were conducted in MEDLINE, Embase, ClinicalTrials.gov, and Cochrane Library databases. Inclusion criteria were published randomized controlled clinical trials from 1989 to 2014 comparing any postoperative preventative measures of intrauterine adhesion after hysteroscopy. The main outcome measure was a reduction in postoperative intrauterine adhesion. Heterogeneity of the studies was evaluated using a Q test and an I(2) index. Analyses were performed using a random-effects model with outcome data reported as relative risk with 95% confidence interval.
RESULTS: Twelve studies were included in the systematic review. Eight studies compared similar treatment methods and were included in the meta-analysis. Three studies evaluated hyaluronic acid gel, of which 2 reported a significant decrease in intrauterine adhesion with treatment. The meta-analysis demonstrated a significant reduction of intrauterine adhesion when using hyaluronic acid gel. Two studies evaluated polyethylene oxide-sodium carboxymethylcellulose gel, 1 of which demonstrated a decrease in intrauterine adhesion with treatment. A meta-analysis showed a significant reduction of intrauterine adhesion with polyethylene oxide-sodium carboxymethyl cellulose gel. However, these 3 studies demonstrating a benefit of the gels in preventing adhesion formation were all conducted by the same research group. Other research groups have not confirmed these results. A sensitivity analysis excluding these trials from this single group demonstrated no benefit to adhesion prevention with either gel formation. Three studies investigated oral estrogen therapy after hysteroscopy and found no difference in intrauterine adhesion. A meta-analysis showed no decrease in intrauterine adhesion with estrogen therapy after hysteroscopy. Data were lacking to perform metaanalyses on the use of intrauterine balloon, intrauterine device, and other adhesion prevention barriers in preventing intrauterine adhesion.
CONCLUSION: There was a lack of definitive evidence to conclude that any treatment is effective in preventing posthysteroscopy uterine adhesion formation. The available literature has significant heterogeneity and a high risk of bias, making any definitive conclusions difficult. Published by Elsevier Inc.

Entities:  

Keywords:  intrauterine adhesion; meta-analysis; operative hysteroscopy; prevention strategy

Mesh:

Year:  2016        PMID: 27173082     DOI: 10.1016/j.ajog.2016.05.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

Review 1.  Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility.

Authors:  Jan Bosteels; Steven Weyers; Thomas M D'Hooghe; Helen Torrance; Frank J Broekmans; Su Jen Chua; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2017-11-27

2.  Hysteroscopic resection of type 3 fibroids could improve the pregnancy outcomes in infertile women: a case-control study.

Authors:  Ying Han; Ruqiang Yao; Yinfeng Zhang; Zexin Yang; Haining Luo; XinYan Wang; Aijun Du; Yunshan Zhang; Yingjun Zhu
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-28       Impact factor: 3.105

3.  The Mechanism of Wnt Pathway Regulated by Telocytes to Promote the Regeneration and Repair of Intrauterine Adhesions.

Authors:  Cai-Zhen Zhao; Ping Fu; Wen-Ying Peng; Na Pan; Yuqiu Peng; Min Zhao; Weiquan Xie
Journal:  Comput Math Methods Med       Date:  2022-07-06       Impact factor: 2.809

4.  Expression and significance of estrogen receptor and progesterone receptor in endometrial tissue of patients with intrauterine adhesions.

Authors:  Jing Ge; Yiwen Chen; Hui Yang; Jingxue Zhao; Dongyan Ren; Xiaomei Wu
Journal:  Gland Surg       Date:  2021-04

Review 5.  Advanced Role of Hippo Signaling in Endometrial Fibrosis: Implications for Intrauterine Adhesion.

Authors:  Hai-Yan Zhu; Tian-Xiang Ge; Yi-Bin Pan; Song-Ying Zhang
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

6.  Growth hormone promotes human endometrial glandular cells proliferation and motion through the GHR-STAT3/5 pathway.

Authors:  Qing Feng; Bingsi Gao; Huan Huang; Lingxiao Zou; Xingping Zhao; Xiuting Zhu; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-02

Review 7.  Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision.

Authors:  Wen-Ling Lee; Chia-Hao Liu; Min Cheng; Wen-Hsun Chang; Wei-Min Liu; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 8.  Recent Advances in Understandings Towards Pathogenesis and Treatment for Intrauterine Adhesion and Disruptive Insights from Single-Cell Analysis.

Authors:  Ross Ka-Kit Leung; Yixin Lin; Yanhui Liu
Journal:  Reprod Sci       Date:  2020-10-30       Impact factor: 3.060

9.  MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.

Authors:  Linlin Wang; Dan Liu; Jun Wei; Liwei Yuan; Shiyun Zhao; Yani Huang; Jingwen Ma; Zhijuan Yang
Journal:  Pathol Oncol Res       Date:  2021-04-29       Impact factor: 3.201

10.  Noninvasive assessment of endometrial fibrosis in patients with intravoxel incoherent motion MR imaging.

Authors:  Qing Hu; Peipei Jiang; Yongjing Feng; Yan Xu; Nan Zhou; Weibo Chen; Li Zhu; Yali Hu; Zhengyang Zhou
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.